-
-
-
-
-
-
-
Biogen (BIIB) to Advance Investigational Spinal Muscular Atrophy Asset to Registrational Studies Based on Positive Interim Phase 1 Results
-
-
-
-
-
-
-
Ionis and Royalty Pharma enter into royalty agreement for up to $1.1 billion to further advance Ionis' genetic medicines and commercial readiness
-
-
-
-
-
-
-
Ionis reports second quarter 2021 financial results and recent business achievements
-
-
-
-
-
-
-
After-Hours Stock Movers 03/22: (BLFS) (CHMA) (PTGX) Higher; (IONS) (RAVN) (QS) Lower (more...)
-
-
-
-
-
-
-
Ionis reports third quarter 2020 financial results and recent business achievements
-
-
-
-
-
-
-
Akcea Therapeutics (AKCA) Announces Appointment of New CFO
-
-
-
-
-
-
-
Ionis Pharmaceuticals (IONS) Announces Dr. Michael Hayden & Peter N. Reikes to Board
-
1,158,060 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

